Becker's Oncology

Receiving a personalized mRNA-based cancer vaccine alongside immunotherapy lowered the risk of recurrence or death by 42% versus immunotherapy alone in a phase 3 clinical trial of patients with surgically resected stage 2B to 4 melanoma. The vaccine, called intismeran…

Commercial insurers initially rejected 84% of new specialty oral blood cancer drug prescriptions, while Medicare plans rejected 64.9%, according to a study published Sept. 30 in the Journal of Clinical Oncology. Researchers from Philadelphia-based University of Pennsylvania analyzed prescription and…

Two recent studies have uncovered disparities in cervical cancer screening and vaccination rates, highlighting the uneven uptake of prevention strategies across the U.S. In one study, published Oct. 16 in JAMA Network Open, researchers from the University of Texas Health…

New Orleans-based LCMC Health will launch a no-cost genetic screening initiative to help 100,000 adults identify inherited risks for certain cancers and heart disease. The Uniquely You program, in collaboration with genomics company Helix, will allow participants to provide DNA…

Nebraska Medicine set out to use AI on a job its nurses spend thousands of hours on each year: pulling data from patient charts for its cancer registry. Two months later, the Omaha-based health system pulled the plug. The registry…